'Bcg vaccine' presentation slideshows

New Drugs and Vaccines in Tuberculosis

746 views • 52 slides

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB). TB in the United States. From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported in 1993 Since 1993, cases are steadily declining.

566 views • 45 slides

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB). TB in the United States. From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported in 1993 Since 1993, cases are steadily declining.

644 views • 45 slides

Poor Eating H abits

571 views • 44 slides

1.18k views • 40 slides

Stop biologics prior to delivery !

422 views • 27 slides

BCG complications

BCG complications. BCG: complications. Local ulcers and regional lymphadenitis in normal hosts: 4 to 30 per 1000 vaccinated infants Osteomyelitis (0.1 to 30 per 100,000 doses) Disseminated BCG infection (0.1 per 100,000 doses Death: 0.02 per million.

1.04k views • 26 slides

Sask BCG Discontinuation

Sask BCG Discontinuation. Dr. Ibrahim Khan Saskatchewan TB Education Day 28 th October, 2011. Overview Purpose Background Criteria for use/discontinuation of BCG Discussion. Purpose

371 views • 24 slides

National Regulatory Authority Republic of Cuba

487 views • 22 slides

Screening and Treating Pediatric TB

Screening and Treating Pediatric TB. David Hilmers, MD January 9, 2006. Epidemiology. Worldwide 8 million new cases (all ages) each year 3 million deaths per year US 1000 kids develop active TB each year Highest rates in minorities Texas is among highest states for new cases.

433 views • 20 slides

Tuberculosis

816 views • 15 slides

Tuberculosis (T.B.)

454 views • 12 slides

Intellectual Property, transfer and accessibility of medical technologies : between the market and public health

248 views • 11 slides

Abstract

Abstract. Modern chemotherapy has played a major role in our control of tuberculosis. Yet tuberculosis still remains a leading infectious disease worldwide (persistence of tubercle bacillus and inadequacy of the current chemotherapy.)

424 views • 9 slides

Global BCG Vaccine Industry 2015 Market Research Report

The report firstly introduced the BCG Vaccine basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. Read more details at: http://www.bigmarketresearch.com/global-bcg-vaccine-industry-2015-research-report-market

311 views • 9 slides

Tuberculosis Vaccine Market – Global Trends, 2026

Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of the infected person. Two types of TB that are commonly observed include latent TB in which the infected person do not show symptoms and active TB in which the infected person shows clinical symptoms of TB. Clinical symptoms and signs of TB include fever, night sweats, cough, weight loss, hemoptysis (coughing up blood-stained sputum), fatigue, chest pain, and shortness of breath. Depending upon the symptoms, TB may be classified as pulmonary TB, subcutaneous TB or military TB.

95 views • 8 slides

BCG Vaccine Market Expected to Grow Rapidly by 2023

The BCG vaccine market is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market. Get sample copy: https://goo.gl/oHbpbY

75 views • 6 slides

Overview & Future Scenario of BCG Vaccine Market

As there is no current alternative to BCG vaccine, therefore there is an urgent need to improve the methods used for quality control of BCG. This is possible with the help of technological advancements in the field of genomics and proteomics, which can help in the development of new methods for BCG testing. These advanced testing methods can ensure the safety, quality, and efficacy of BCG vaccine preparations.

62 views • 6 slides

BCG Vaccination

The BCG vaccination protects against Tuberculosis, commonly known as TB. We also offer the Yellow fever vaccination, Private BCG Injection. https://www.olivehealthandtravel.co.uk/bcg-vaccination

62 views • 4 slides

Arc Fault Circuit Interrupter (AFCI) Market Size, Share, Drivers & Trends Analysis to 2022

This report splits BCG Vaccine by Types, End Users. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details.

73 views • 3 slides